NEW YORK, Dec. 27, 2025, 9:00 a.m. ET — Market closed.
Singapore Exchange (SGX) heads into the final weekend of the year with two cross-currents that matter for both Singapore equities and the exchange operator itself: a quiet, liquidity-thinned post‑Christmas session that left the Straits Times Index (STI) essentially unchanged, and a fresh burst of macro data showing Singapore’s manufacturing engine still growing at a double‑digit pace—though slower than October’s surge. [1]
With U.S. markets shut for the weekend in New York, the immediate question for global investors isn’t what happens “today,” but what could gap prices at Monday’s reopen—especially in a year‑end environment where positioning, thin volumes, and headline risk can matter more than normal. That dynamic is relevant for SGX in two ways: it shapes near‑term trading appetite in Singapore-listed stocks, and it can influence volatility and hedging demand across SGX’s derivatives complex (equity index, FX and commodities). [2]
Where SGX and Singapore stocks left off on Friday
Shares of Singapore Exchange Ltd (ticker: S68) ended Friday’s session at S$17.13, down 0.75% on the day, with about 706,600 shares traded, according to Financial Times market data (delayed). FT also shows the stock up about 37.8% over the past year—an eye-catching run into year-end. [3]
In the broader market, Singapore stocks finished flat on Dec. 26, with the STI edging down by just 0.19 point to close at 4,636.15. Market breadth was mildly positive—gainers beat losers 225 to 170—with about 764.9 million securities worth S$667.8 million changing hands, according to a market wrap published by The Business Times and republished by The Straits Times. [4]
A few blue-chip moves helped illustrate the tone: Thai Beverage was among the stronger STI performers, while Jardine Matheson was cited as the weakest. Local banks ended mixed. None of that screams “panic” or “euphoria”—it looks like late‑December market choreography: show up, trade a little, don’t break anything expensive. [5]
The macro catalyst in the last 24–48 hours: Singapore factory output surprises (again)
The biggest “fresh” datapoint for Singapore-focused investors over the last 24–48 hours was industrial production.
Singapore’s manufacturing output rose 14.3% year-on-year in November, according to the Singapore Economic Development Board (EDB). Strip out biomedical manufacturing—often the most volatile component—and output was still up 4.6% year-on-year. On a seasonally adjusted month-on-month basis, total output fell 10.2%. [6]
Under the hood, the EDB breakdown shows why the headline is both strong and slightly tricky:
